BioCardia, Inc.
BCDA
$1.10
-$0.01-0.90%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -27.69% | 9.49% | |||
| Gross Profit | 27.69% | -9.49% | |||
| SG&A Expenses | -29.19% | 16.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -28.38% | 12.57% | |||
| Operating Income | 28.38% | -12.57% | |||
| Income Before Tax | 28.60% | -13.86% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 28.60% | -13.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 28.60% | -13.86% | |||
| EBIT | 28.38% | -12.57% | |||
| EBITDA | 28.41% | -12.59% | |||
| EPS Basic | 36.14% | -12.43% | |||
| Normalized Basic EPS | 36.14% | -12.49% | |||
| EPS Diluted | 36.14% | -12.43% | |||
| Normalized Diluted EPS | 36.14% | -12.49% | |||
| Average Basic Shares Outstanding | 11.85% | 1.27% | |||
| Average Diluted Shares Outstanding | 11.85% | 1.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||